Product Program year 2022 Source: CMS Open Payments

General - Vascular Access

Device Embolics

Open in the dashboard

General payments

$2,858

11 payments

Research payments

$0

0 payments

Through program year 2022, $2,858 in general payments and $0 in research payments were reported against General - Vascular Access (Embolics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2022 General $2,858 11

Breakdown

Who paid General payments · program year 2022
  1. Boston Scientific Corporation $2,858 11 payments
Top recipients General payments · program year 2022
  1. David Quintana Vascular & Interventional Radiology · Englewood, CO $2,500 87% · 1 payment
  2. Mario Moya Vascular & Interventional Radiology · Newtown Square, PA $80 3% · 1 payment
  3. Morgan Whitmore Vascular & Interventional Radiology · Atlanta, GA $76 3% · 1 payment
  4. Darren Kies Vascular & Interventional Radiology · Atlanta, GA $76 3% · 1 payment
  5. Eric Kleinbaum Hematology & Oncology · Houston, TX $25 <1% · 1 payment

The top 5 of 11 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Vascular & Interventional Radiology Radiology $2,784 97% · 7 practitioners
  2. Hematology & Oncology Internal Medicine $25 <1% · 1 practitioner
  3. Nurse Practitioner $19 <1% · 1 practitioner
  4. Nurse Practitioner, Family Nurse Practitioner $19 <1% · 1 practitioner
  5. Diagnostic Radiology Radiology $10 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2022
  1. Texas $2,546 89% · 3 recipients
  2. Georgia $153 5% · 2 recipients
  3. Pennsylvania $80 3% · 1 recipient
  4. California $39 1% · 2 recipients
  5. Louisiana $25 <1% · 1 recipient

The top 5 of 7 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

11 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record